Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Cruise tourism is at a record high with more than 30 million passengers expected to sail the open waters this year. That’s why we’re sitting down with Bill Panoff, editor in chief of Porthole Cruise Magazine, to discuss all things cruises.

What began in 1993 as a trade publication by longtime cruise director and lifelong cruise enthusiast Bill Panoff quickly transformed into a consumer magazine, for which he still serves as publisher and editor-in-chief. From cover to cover, Porthole Cruise Magazine features sophisticated cruise and travel editorial for savvy consumers worldwide.

Expert writers and columnists cover everything from the latest trends in cruise travel to ship reviews, destination features, and onboard cuisine, entertainment, amenities, innovations, spas, and more. And you can’t miss Porthole Cruise Magazine’s award-winning photography. With its vivid color and up-close and personal sights, the pictures will certainly speak thousands more words. It’s published every two months, available by subscription, on newsstands, and in major retail outlets.

By reading Porthole Cruise Magazine — either in its print form or digital edition — you’ll discover there is a cruise out there for all tastes, budgets, and travel dreams. It’s up to you to decide where to let those desires lead you. Where do you want to cruise? Yep, you don’t want to miss this!

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments